IL2RA and acute lymphoblastic leukemia: CD25 alone has the advantage as a T-ALL LIC target because of its absence except activated T cells and a sub-population of memory CD8+ cells and there is little evidence of expression outside the immune system http://www.proteinatlas.org/ENSG00000134460-IL2RA/tissue.